Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

Promoting cancer genomics research in Africa: a roadmap

Nature Reviews Cancer volume 21, pages 409–410 (2021)Cite this article

Subjects

Cancer genomics research in Africa is crucial to understanding the genetic architecture of cancer and tailoring cancer diagnoses and therapies to African populations. Creating this research enterprise in Africa has to be purposeful with a roadmap that incorporates individual scientist-, international collaborator-, university or institution-, and scientific organization-level factors.

Morbidity and mortality from non-communicable diseases, such as cancer, will surpass that of communicable diseases in Africa by 2030 (ref.1). Alarmingly, Africa leads other continents in terms of the predicted percent changes of cancer incidence and mortality from 2020 to 2040, with an expected increase of 92.9% for cancer mortality and 89.1% for new cancer cases2. Cancer continues to create a huge clinical, economic and humanistic burden for Africa as a continent. To effectively address the disproportionate burden of cancer in Africa, we must understand what drives the development and growth of different types of cancer in African populations. The field of cancer genomics holds the promise to study the genetic architecture of cancer and develop new tools to diagnose and treat cancer in Africa. Unfortunately, individuals of African origin constitute less than 3% of study participants in genome-wide association studies (GWAS)3 although Africa has the most diverse human populations, accounting for 17% of the global population. Genetically, Africa is home to five (East Africans, West Africans, Central African Hunter-Gatherers, Northern Khoe-San and Nouthern Khoe-San) out of the six distinct groups in the human population structure, with the sixth representing all the out-of-Africa populations4. Hence, the limited representation of African populations in cancer genomics research (CGR) continues to contribute to global cancer disparities due to the lack of understanding of the biology of cancer in African populations5,6. Out of over 700,000 cancer genetics or genomics studies in PubMed, less than 500 utilized African biospecimens. For these African cancer genetics studies, GWAS or genome sequencing studies were mainly on populations in North African countries and South Africa; hence, many African populations are not represented6.

This is a preview of subscription content, access via your institution

Access options

Rent or buy this article

Get just this article for as long as you need it

$39.95

Learn more

Prices may be subject to local taxes which are calculated during checkout

References

  1. NCD Countdown. NCD Countdown 2030: worldwide trends in non-communicable disease mortality and progress towards Sustainable Development Goal target 3.4. Lancet 392, 1072–1088 (2018).

    Article  Google Scholar 

  2. Sung, H. et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J. Clin. https://doi.org/10.3322/caac.21660 (2021).

    Article  PubMed  Google Scholar 

  3. Gurdasani, D., Barroso, I., Zeggini, E. & Sandhu, M. S. Genomics of disease risk in globally diverse populations. Nat. Rev. Genet. 20, 520–535 (2019).

    Article  CAS  Google Scholar 

  4. Schlebusch, C. M. et al. Southern African ancient genomes estimate modern human divergence to 350,000 to 260,000 years ago. Science 358, 652–655 (2017).

    Article  CAS  Google Scholar 

  5. Drake, T. M., Knight, S. R., Harrison, E. M. & Soreide, K. Global inequities in precision medicine and molecular cancer research. Front. Oncol. 8, 346 (2018).

    Article  Google Scholar 

  6. Rotimi, S. O., Rotimi, O. A. & Salhia, B. A review of cancer genetics and genomics studies in Africa. Front. Oncol. 10, 606400 (2020).

    Article  Google Scholar 

  7. Rotimi, S. O., Rotimi, O. A. & Salhia, B. Authorship patterns in cancer genomics publications across Africa. JCO Glob. Oncol. in press (2021).

  8. Weber-Main, A. M., Finstad, D. A., Center, B. A. & Bland, C. J. An adaptive approach to facilitating research productivity in a primary care clinical department. Acad. Med. 88, 929–938 (2013).

    Article  Google Scholar 

  9. Odedina, F. T. et al. Increasing the representation of minority students in the biomedical workforce: the ReTOOL program. J. Cancer Educ. 34, 577–583 (2019).

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. University of Florida, Orlando, FL, USA

    Folakemi T. Odedina

  2. Covenant University, Ota, Ogun State, Nigeria

    Solomon Rotimi

Authors
  1. Folakemi T. Odedina
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Solomon Rotimi
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding authors

Correspondence to Folakemi T. Odedina or Solomon Rotimi.

Ethics declarations

Competing interests

The authors declare no competing interests.

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Odedina, F.T., Rotimi, S. Promoting cancer genomics research in Africa: a roadmap. Nat Rev Cancer 21, 409–410 (2021). https://doi.org/10.1038/s41568-021-00359-9

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/s41568-021-00359-9

Search

Advanced search

Quick links

Nature Briefing: Cancer

Sign up for the Nature Briefing: Cancer newsletter — what matters in cancer research, free to your inbox weekly.

Get what matters in cancer research, free to your inbox weekly. Sign up for Nature Briefing: Cancer